Drug Metabolism
and Pharmacokinetics Service

The DMPK Service Department is one of the business units under the Laboratory Testing Division. It is primarily responsible for in vivo and in vitro pharmacokinetics studies. When you partner with WuXi AppTec for drug discovery and development services, you gain access to an integrated worldwide network of facilities that offer a full range of discovery screening, preclinical development, clinical drug metabolism, and pharmacokinetic (DMPK) platforms and services. These include in vitro absorption, distribution, metabolism, and excretion (ADME) studies and in vivo pharmacokinetic studies, metabolite identification studies, quantitative autoradiography studies, human radioactive substance balance, and metabolite safety evaluation studies. With locations in the United States (New Jersey) and China (Shanghai, Suzhou, Nanjing, and Nantong), we can help you navigate every aspect of the drug development process—no matter what the stage.

The DMPK Service Department has a diversified client community, covering more than 90% of the world’s large pharmaceutical companies with more than 1,000 small and medium-sized biopharmaceutical companies, virtual companies, non-profit organizations, and academic institutions. As a global DMPK service provider, we are committed to delivering all clients with high-quality data, precise R&D strategies, and excellent services to meet the unique needs of every client and become the preferred partner for DMPK studies.